Condition: Ornithine Transcarbamylase Deficiency · Ornithine Transcarbamylase Deficiency Disease · Urea Cycle Disorders, Inborn · Sponsor: iECURE, Inc.
This LTFU is being conducted to assess long-term safety and durability of response in participants dosed with IP in a parent protocol, and to collect longitudinal natural history in enrolled but not dosed participants who also participated in a parent protocol.
This description comes directly from the study's public registry record.
George Diaz, M.D., Ph.D. · 1-877-694-3558 · medinfo@iecure.com
Always discuss trial participation with your own doctor first.
| Great Ormond Street Hospital | London, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06805695